PLXP · PLx Pharma Inc
Acquired Company
Dipexium Pharmaceuticals acquired PLx Pharma in a merger completed on 4/19/2017.
PLx Pharma Inc. is a late-stage specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard™ drug delivery platform to provide more effective and safer products. The PLxGuard drug delivery platform works by targeting the release of active pharmaceutical ingredients to various portions of the gastrointestinal (GI) tract. PLx believes this has the potential to improve the absorption of many drugs currently on the market or in development, and to reduce the risk of stomach erosions and ulcers associated with aspirin and ibuprofen, and potentially other drugs.
Market Cap
N/A
52 Wk Range
N/A - N/A
Previous Close
$0.00
Open
$0.00
Volume
3,000
Day Range
$0.00 - $0.00
Enterprise Value
N/A
Cash
N/A
Avg Qtr Burn
N/A
Insider Ownership
15.39%
Institutional Own.
23.26%
Qtr Updated
Sep 30th 2024
